Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) EBT Margin (2016 - 2025)

Skinvisible (SKVI) has disclosed EBT Margin for 16 consecutive years, with 5167.14% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 218098.0% to 5167.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5342.82% through Dec 2025, up 95232.0% year-over-year, with the annual reading at 5342.82% for FY2025, 95232.0% up from the prior year.
  • EBT Margin hit 5167.14% in Q4 2025 for Skinvisible, down from 5004.9% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 51.75% in Q2 2021 to a low of 30240.36% in Q1 2023.
  • Historically, EBT Margin has averaged 5559.05% across 5 years, with a median of 5593.02% in 2023.
  • Biggest five-year swings in EBT Margin: crashed -2962497bps in 2023 and later surged 2444852bps in 2024.
  • Year by year, EBT Margin stood at 182.58% in 2021, then tumbled by -4379bps to 8177.86% in 2022, then rose by 26bps to 6085.9% in 2023, then decreased by -21bps to 7348.12% in 2024, then rose by 30bps to 5167.14% in 2025.
  • Business Quant data shows EBT Margin for SKVI at 5167.14% in Q4 2025, 5004.9% in Q3 2025, and 5579.14% in Q2 2025.